These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 21713346)

  • 1. [New approaches for allergen-specific immunotherapy].
    Cantillo JF; Puerta L
    Biomedica; 2010; 30(3):440-53. PubMed ID: 21713346
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Allergen-related approaches to immunotherapy.
    Rolland JM; Gardner LM; O'Hehir RE
    Pharmacol Ther; 2009 Mar; 121(3):273-84. PubMed ID: 19111571
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Developments in allergen-specific immunotherapy: from allergen extracts to allergy vaccines bypassing allergen-specific immunoglobulin E and T cell reactivity.
    Focke M; Swoboda I; Marth K; Valenta R
    Clin Exp Allergy; 2010 Mar; 40(3):385-97. PubMed ID: 20210812
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recent progress in allergen immunotherapy.
    Nouri-Aria KT
    Iran J Immunol; 2008 Mar; 5(1):1-24. PubMed ID: 18319521
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic allergen modification in the development of novel approaches to specific immunotherapy.
    Mutschlechner S; Deifl S; Bohle B
    Clin Exp Allergy; 2009 Nov; 39(11):1635-42. PubMed ID: 19624521
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Allergy diagnosis, allergen repertoires, and their implications for allergen-specific immunotherapy.
    Crameri R
    Immunol Allergy Clin North Am; 2006 May; 26(2):179-89, v. PubMed ID: 16701139
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunotherapy with peptides.
    Moldaver D; Larché M
    Allergy; 2011 Jun; 66(6):784-91. PubMed ID: 21507007
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mechanisms of allergen-specific immunotherapy and novel ways for vaccine development.
    Jutel M; Van de Veen W; Agache I; Azkur KA; Akdis M; Akdis CA
    Allergol Int; 2013 Dec; 62(4):425-33. PubMed ID: 24153333
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High-affinity IgG to a major A. fumigatus allergen, Asp f 2, retards allergic response.
    Svirshchevskaya EV; Viskova N; Shevchenko M; Alekseeva L; Marchenko A; Benevolensky S; Kurup VP
    Med Sci Monit; 2004 Oct; 10(10):BR371-80. PubMed ID: 15448590
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanisms of allergen-specific immunotherapy: T-regulatory cells and more.
    Verhagen J; Blaser K; Akdis CA; Akdis M
    Immunol Allergy Clin North Am; 2006 May; 26(2):207-31, vi. PubMed ID: 16701141
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Specific immunotherapy and turning off the T cell: how does it work?
    Ozdemir C; Kucuksezer UC; Akdis M; Akdis CA
    Ann Allergy Asthma Immunol; 2011 Nov; 107(5):381-92. PubMed ID: 22018608
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Allergen immunotherapy.
    Huggins JL; Looney RJ
    Am Fam Physician; 2004 Aug; 70(4):689-96. PubMed ID: 15338781
    [TBL] [Abstract][Full Text] [Related]  

  • 13. IgE-facilitated antigen presentation: role in allergy and the influence of allergen immunotherapy.
    Wilcock LK; Francis JN; Durham SR
    Immunol Allergy Clin North Am; 2006 May; 26(2):333-47, viii-ix. PubMed ID: 16701148
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeting dendritic cells in allergen immunotherapy.
    Novak N
    Immunol Allergy Clin North Am; 2006 May; 26(2):307-19, viii. PubMed ID: 16701146
    [TBL] [Abstract][Full Text] [Related]  

  • 15. DNA-based approaches to the treatment of allergies.
    Spiegelberg HL; Raz E
    Curr Opin Mol Ther; 2002 Feb; 4(1):64-71. PubMed ID: 11883696
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Medication with antihistamines impairs allergen-specific immunotherapy in mice.
    Johansen P; Senti G; Maria Martínez Gómez J; Kündig TM
    Clin Exp Allergy; 2008 Mar; 38(3):512-9. PubMed ID: 18081882
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immune mechanisms of allergen-specific sublingual immunotherapy.
    Moingeon P; Batard T; Fadel R; Frati F; Sieber J; Van Overtvelt L
    Allergy; 2006 Feb; 61(2):151-65. PubMed ID: 16409190
    [TBL] [Abstract][Full Text] [Related]  

  • 18. IgE-mediated allergen presentation and blocking antibodies: regulation of T-cell activation in allergy.
    van Neerven RJ; Knol EF; Ejrnaes A; Würtzen PA
    Int Arch Allergy Immunol; 2006; 141(2):119-29. PubMed ID: 16864979
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mechanisms of subcutaneous allergen immunotherapy.
    Soyer OU; Akdis M; Akdis CA
    Immunol Allergy Clin North Am; 2011 May; 31(2):175-90, vii-viii. PubMed ID: 21530813
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Allergen-specific T lymphocytes as targets for specific immunotherapy: striking at the roots of type I allergy.
    Bohle B
    Arch Immunol Ther Exp (Warsz); 2002; 50(4):233-41. PubMed ID: 12371619
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.